Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Autonomous adaptation of transmit power
Transporting business intelligence objects between business intelligence systems
Clock face
Method and apparatus for verifiable generation of public keys
Charging member, electrophotographic apparatus, and process cartridge
Cryptography on a simplified elliptical curve
Data processing apparatus including reconfigurable logic circuit
  Randomly Featured Patents
Selective synthesis of CF3-substituted pyrimidines
Apparatus and method for decoding differential multi-level data with adaptive threshold control
Flash memory management method
Mobile car crusher
Image recording medium and method of making same
(S)-emopamil for the treatment of migraine
Methods and systems for automated prepaid service routing
Chicken cage stacker
Bottle carrier